These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8843291)

  • 21. Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.
    Donati M; Rodrìguez Fermepin M; Olmo A; D'Apote L; Cevenini R
    J Antimicrob Chemother; 1999 Jun; 43(6):825-7. PubMed ID: 10404322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae.
    Hammerschlag MR; Roblin PM
    J Antimicrob Chemother; 2004 Jul; 54(1):281-2. PubMed ID: 15190026
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.
    Chotikanatis K; Kohlhoff SA; Hammerschlag MR
    Antimicrob Agents Chemother; 2014; 58(3):1800-1. PubMed ID: 24366753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro activity of garenoxacin against Chlamydia spp.
    Donati M; Pollini GM; Sparacino M; Fortugno MT; Laghi E; Cevenini R
    J Antimicrob Chemother; 2002 Sep; 50(3):407-10. PubMed ID: 12205067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.
    Roblin PM; Hammerschlag MR
    Int J Antimicrob Agents; 2000 Sep; 16(1):61-3. PubMed ID: 11185415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae.
    Miyashita N; Fukano H; Niki Y; Matsushima T
    J Antimicrob Chemother; 2001 Sep; 48(3):403-5. PubMed ID: 11533006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.
    Ljubin-Sternak S; Mestrovic T; Vilibic-Cavlek T; Mlinaric-Galinovic G; Sviben M; Markotic A; Skerk V
    Folia Microbiol (Praha); 2013 Sep; 58(5):361-5. PubMed ID: 23271498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
    Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
    Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and antimicrobial susceptibilities of Chlamydial isolates from Western barred bandicoots.
    Kumar S; Kutlin A; Roblin P; Kohlhoff S; Bodetti T; Timms P; Hammerschlag MR
    J Clin Microbiol; 2007 Feb; 45(2):392-4. PubMed ID: 17122017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia.
    Roblin PM; Montalban G; Hammerschlag MR
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1588-9. PubMed ID: 7979292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.
    Critchley IA; Jones ME; Heinze PD; Hubbard D; Engler HD; Evangelista AT; Thornsberry C; Karlowsky JA; Sahm DF
    Clin Microbiol Infect; 2002 Apr; 8(4):214-21. PubMed ID: 12047413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae.
    Roblin PM; Reznik T; Kutlin A; Hammerschlag MR
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2806-7. PubMed ID: 10543770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia.
    Niki Y; Kimura M; Miyashita N; Soejima R
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2296-9. PubMed ID: 7840560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlamydia pneumoniae enhances Interleukin 8 (IL-8) production with reduced azithromycin sensitivity under hypoxia.
    Matsuo J; Sakai K; Okubo T; Yamaguchi H
    APMIS; 2019 Mar; 127(3):131-138. PubMed ID: 30746791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma.
    Smith-Norowitz TA; Weaver D; Norowitz YM; Hammerschlag MR; Joks R; Durkin HG; Kohlhoff S
    J Infect Chemother; 2018 Jun; 24(6):470-475. PubMed ID: 29615379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
    Samra Z; Rosenberg S; Soffer Y; Dan M
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.
    Strigl S; Roblin PM; Reznik T; Hammerschlag MR
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1112-3. PubMed ID: 10722526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlamydia pneumoniae resists antibiotics in lymphocytes.
    Yamaguchi H; Friedman H; Yamamoto M; Yasuda K; Yamamoto Y
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1972-5. PubMed ID: 12760877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae.
    Khan MA; Potter CW; Sharrard RM
    J Antimicrob Chemother; 1996 Apr; 37(4):677-85. PubMed ID: 8722533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model.
    Kutlin A; Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2268-72. PubMed ID: 10471577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.